Compounds > 4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide
Page last updated: 2024-10-30

4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide and HIV Coinfection

4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide has been researched along with HIV Coinfection in 1 studies

4-(dimethylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)benzamide: structure in first source
4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide : A benzamide resulting from the formal condensation of the carboxy group of 4-(dimethylamino)benzoic acid with the amino group of 7-amino-N-hydroxyheptanamide. It is a potent inhibitor of histone deacetylases and induces cell cycle arrest and apoptosis in several human cancer cell lines.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lopes, JR1
Chiba, DE1
Dos Santos, JL1

Reviews

1 review available for 4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide and HIV Coinfection

ArticleYear
HIV latency reversal agents: A potential path for functional cure?
    European journal of medicinal chemistry, 2021, Mar-05, Volume: 213

    Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Histone Deacetylase Inhibitors; HIV Infections; HIV-1;

2021